Embelin inhibits viability of cutaneous T cell lymphoma cell lines HuT78 and H9 by targeting inhibitors of apoptosis

References

• Hwang ST, Janik JE, Jaffe ES, et al. Mycosis fungoides and sézary syndrome. Lancet. 2008;371(9616):945–957. doi:10.1016/S0140-6736(08)60420-1
   PubMed Web of Science ®Google Scholar
• Devata S, Wilcox RA. Cutaneous T-cell lymphoma: a review with a focus on targeted agents. Am J Clin Dermatol. 2016;17(3):225–237. doi:10.1007/s40257-016-0177-5
   PubMed Web of Science ®Google Scholar
• Nakai S, Kiyohara E, Watanabe R. Malignant and benign T cells constituting cutaneous T-cell lymphoma. Int J Mol Sci. 2021;22:12933.
   PubMed Web of Science ®Google Scholar
• Molloy K, Jonak C, Woei AJF, et al. Characteristics associated with significantly worse quality of life in mycosis fungoides/sézary syndrome from the prospective cutaneous lymphoma international prognostic index (PROCLIPI) study. Br J Dermatol. 2020;182(3):770–779. doi:10.1111/bjd.18089
   PubMed Web of Science ®Google Scholar
• Brunner PM, Jonak C, Knobler R. Recent advances in understanding and managing cutaneous T-cell lymphomas. F1000Res. 2020;9:331. doi:10.12688/f1000research.21922.1
   Google Scholar
• Hristov AC, Tejasvi T, Wilcox RA. Mycosis fungoides and sézary syndrome: 2019 update on diagnosis, risk-stratification, and management. Am J Hematol. 2019;94(9):1027–1041. doi:10.1002/ajh.25577
   PubMed Web of Science ®Google Scholar
• Pan ST, Li ZL, He ZX, et al. Molecular mechanisms for tumour resistance to chemotherapy. Clin Exp Pharmacol Physiol. 2016;43(8):723–737. doi:10.1111/1440-1681.12581
   PubMed Web of Science ®Google Scholar
• Makgoo L, Mosebi S, Mbita Z. Long noncoding RNAs (lncRNAs) in HIV-mediated carcinogenesis: role in cell homeostasis, cell survival processes and drug resistance. Noncoding RNA Res. 2022;7(3):184–196. doi:10.1016/j.ncrna.2022.07.003
   PubMed Web of Science ®Google Scholar
• Wollina U. Cutaneous T cell lymphoma: update on treatment. Int J Dermatol. 2012;51(9):1019–1036. doi:10.1111/j.1365-4632.2011.05337.x
   PubMed Web of Science ®Google Scholar
• Pezzani R, Salehi B, Vitalini S, et al. Synergistic effects of plant derivatives and conventional chemotherapeutic agents: an update on the cancer perspective. Medicina (Kaunas). 2019;55(4):110. doi:10.3390/medicina55040110
   PubMed Web of Science ®Google Scholar
• Yuan R, Hou Y, Sun W, et al. Natural products to prevent drug resistance in cancer chemotherapy: a review. Ann NY Acad Sci. 2017;1401(1):19–27. doi:10.1111/nyas.13387
   PubMed Web of Science ®Google Scholar
• Steinhoff M, Alam M, Ahmad A, et al. Targeting oncogenic transcription factors in skin malignancies: an update on cancer stemness and therapeutic outcomes. Semin Cancer Biol. 2022;87:98–116. doi:10.1016/j.semcancer.2022.11.009
   PubMed Web of Science ®Google Scholar
• Zappavigna S, Cossu AM, Grimaldi A, et al. Anti-Inflammatory drugs as anticancer agents. Int J Mol Sci. 2020;21:2605.
   PubMed Web of Science ®Google Scholar
• Ko JH, Lee SG, Yang WM, et al. The application of embelin for cancer prevention and therapy. Molecules. 2018;23(3):23.
   Web of Science ®Google Scholar
• Prabhu KS, Achkar IW, Kuttikrishnan S, et al. Embelin: a benzoquinone possesses therapeutic potential for the treatment of human cancer. Future Med Chem. 2018;10(8):961–976. doi:10.4155/fmc-2017-0198
   PubMed Web of Science ®Google Scholar
• Nikolovska-Coleska Z, Xu L, Hu Z, et al. Discovery of embelin as a cell-permeable, small-molecular weight inhibitor of XIAP through structure-based computational screening of a traditional herbal medicine three-dimensional structure database. J Med Chem. 2004;47(10):2430–2440.
   PubMed Web of Science ®Google Scholar
• Zhou HZ, Zeng HQ, Yuan D, et al. NQO1 potentiates apoptosis evasion and upregulates XIAP via inhibiting proteasome-mediated degradation SIRT6 in hepatocellular carcinoma. Cell Commun Signal. 2019;17(1):168. doi:10.1186/s12964-019-0491-7
   PubMed Web of Science ®Google Scholar
• den Besten W, Verma K, Yamazoe S, et al. Primary amine tethered small molecules promote the degradation of X-Linked inhibitor of apoptosis protein. J Am Chem Soc. 2021;143(28):10571–10575. doi:10.1021/jacs.1c05269
   PubMed Web of Science ®Google Scholar
• Hu R, Zhu K, Li Y, et al. Embelin induces apoptosis through down-regulation of XIAP in human leukemia cells. Med Oncol. 2011;28(4):1584–1588. doi:10.1007/s12032-010-9601-5
   PubMed Web of Science ®Google Scholar
• Abbas R, Larisch S. Targeting XIAP for promoting cancer cell death-the story of ARTS and SMAC. Cells. 2020;9(3):663. doi:10.3390/cells9030663
   PubMed Web of Science ®Google Scholar
• Bunn PA, Jr., Foss FM. T-cell lymphoma cell lines (HUT102 and HUT78) established at the national cancer institute: history and importance to understanding the biology, clinical features, and therapy of cutaneous T-cell lymphomas (CTCL) and adult T-cell leukemia-lymphomas (ATLL). J Cell Biochem Suppl. 1996;24:12–23.
   PubMedGoogle Scholar
• Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol. 2007;35(4):495–516. doi:10.1080/01926230701320337
   PubMed Web of Science ®Google Scholar
• Ozyerli-Goknar E, Bagci-Onder T. Epigenetic deregulation of apoptosis in cancers. Cancers (Basel). 2021;13(13):3210. doi:10.3390/cancers13133210
   PubMed Web of Science ®Google Scholar
• Abdulrahman N, Siveen KS, Joseph JM, et al. Inhibition of p90 ribosomal S6 kinase potentiates cisplatin activity in A549 human lung adenocarcinoma cells. J Pharm Pharmacol. 2020;72(11):1536–1545. doi:10.1111/jphp.13335
   PubMed Web of Science ®Google Scholar
• McIlwain DR, Berger T, Mak TW. Caspase functions in cell death and disease. Cold Spring Harb Perspect Biol. 2013;5(4):a008656–a008656. doi:10.1101/cshperspect.a008656
   PubMed Web of Science ®Google Scholar
• Herceg Z, Wang ZQ. Functions of poly(ADP-ribose) polymerase (PARP) in DNA repair, genomic integrity and cell death. Mutat Res. 2001;477(1–2):97–110.
   PubMed Web of Science ®Google Scholar
• Mashimo M, Onishi M, Uno A, et al. The 89-kDa PARP1 cleavage fragment serves as a cytoplasmic PAR carrier to induce AIF-mediated apoptosis. J Biol Chem. 2021;296:100046.
   PubMed Web of Science ®Google Scholar
• Sharma A, Singh K, Almasan A. Histone H2AX phosphorylation: a marker for DNA damage. Methods Mol Biol. 2012;920:613–626.
   PubMedGoogle Scholar
• Podhorecka M, Skladanowski A, Bozko P. H2AX phosphorylation: its role in DNA damage response and cancer therapy. J Nucleic Acids. 2010;2010:1–9. doi:10.4061/2010/920161
   Google Scholar
• Prabhu KS, Siveen KS, Kuttikrishnan S, et al. Targeting of X-linked inhibitor of apoptosis protein and PI3-kinase/AKT signaling by embelin suppresses growth of leukemic cells. PLoS One. 2017;12(7):e0180895. doi:10.1371/journal.pone.0180895
   PubMed Web of Science ®Google Scholar
• Hu R, Yang Y, Liu Z, et al. The XIAP inhibitor embelin enhances TRAIL-induced apoptosis in human leukemia cells by DR4 and DR5 upregulation. Tumor Biol. 2015;36(2):769–777. doi:10.1007/s13277-014-2702-6
   PubMedGoogle Scholar
• McGirt LY, Jia P, Baerenwald DA, et al. Whole-genome sequencing reveals oncogenic mutations in mycosis fungoides. Blood. 2015;126(4):508–519. doi:10.1182/blood-2014-11-611194
   PubMed Web of Science ®Google Scholar
• Whibley C, Pharoah PD, Hollstein M. p53 polymorphisms: cancer implications. Nat Rev Cancer. 2009;9(2):95–107. doi:10.1038/nrc2584
   PubMed Web of Science ®Google Scholar
• Gros A, Laharanne E, Vergier M, et al. TP53 alterations in primary and secondary sezary syndrome: a diagnostic tool for the assessment of malignancy in patients with erythroderma. PLoS One. 2017;12(3):e0173171. doi:10.1371/journal.pone.0173171
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhong J, Bai J, et al. The application of natural products in cancer therapy by targeting apoptosis pathways. Curr Drug Metab. 2018;19(9):739–749. doi:10.2174/1389200219666180511154722
   PubMed Web of Science ®Google Scholar
• Yang H, Villani RM, Wang H, et al. The role of cellular reactive oxygen species in cancer chemotherapy. J Exp Clin Cancer Res. 2018;37(1):266. doi:10.1186/s13046-018-0909-x
   PubMed Web of Science ®Google Scholar
• Farhan M, Khan HY, Oves M, et al. Cancer therapy by catechins involves redox cycling of copper ions and generation of reactive oxygen species. Toxins (Basel). 2016;8(2):37. doi:10.3390/toxins8020037
   PubMed Web of Science ®Google Scholar
• Ahmad R, Vaali-Mohammed MA, Elwatidy M, et al. Induction of ROS‑mediated cell death and activation of the JNK pathway by a sulfonamide derivative. Int J Mol Med. 2019;44:1552–1562.
   PubMed Web of Science ®Google Scholar
• Zhu XL, Jiang L, Qu F, et al. Inhibitory effect of embelin on human acute T cell lymphoma jurkat cells through activation of the apoptotic pathway. Oncol Lett. 2015;10(2):921–926. doi:10.3892/ol.2015.3364
   PubMed Web of Science ®Google Scholar
• Al-Yacoub N, Fecker LF, Möbs M, et al. Apoptosis induction by SAHA in cutaneous T-cell lymphoma cells is related to downregulation of c-FLIP and enhanced TRAIL signaling. J Invest Dermatol. 2012;132(9):2263–2274. doi:10.1038/jid.2012.125
   PubMed Web of Science ®Google Scholar
• Krammer PH, Arnold R, Lavrik IN. Life and death in ­peripheral T cells. Nat Rev Immunol. 2007;7(7):532–542. doi:10.1038/nri2115
   PubMed Web of Science ®Google Scholar
• Gunes EG, Kil SH, Wu X, et al. Tnfα promotes an immunosuppressive microenvironment in cutaneous T cell lymphoma and regulates PD-L1 expression. Blood. 2020;136(1):33–34. doi:10.1182/blood-2020-141070
   Google Scholar
• Dhanjal JK, Nigam N, Sharma S, et al. Embelin inhibits TNF-α converting enzyme and cancer cell metastasis: molecular dynamics and experimental evidence. BMC Cancer. 2014;14(1):775. doi:10.1186/1471-2407-14-775
   PubMedGoogle Scholar
• Liang YH, Wu JM, Teng JW, et al. Embelin downregulated cFLIP in breast cancer cell lines facilitate anti-tumor effect of IL-1β-stimulated human umbilical cord mesenchymal stem cells. Sci Rep. 2021;11(1):14720. doi:10.1038/s41598-021-94006-w
   PubMed Web of Science ®Google Scholar
• Li Z, Chen SJ, Yu XA, et al. Pharmacokinetic and bioavailability studies of embelin after intravenous and oral administration to rats. Evid Based Complement Alternat Med. 2019;2019:9682495.
   PubMed Web of Science ®Google Scholar
• Mungai NN, Makawiti DW, Konji VN. Effect of different doses and routes of administration of embelin on plasma testosterone levels. Phytother Res. 1997;11(7):532–534. doi:10.1002/(SICI)1099-1573(199711)11:7<532::AID-PTR144>3.0.CO;2-U
   Web of Science ®Google Scholar
• Reis-Silva CSM, Branco PC, Lima K, et al. Embelin potentiates venetoclax-induced apoptosis in acute myeloid leukemia cells. Toxicol in Vitro. 2021;76:105207. doi:10.1016/j.tiv.2021.105207
   PubMed Web of Science ®Google Scholar